PSMA is a chemical that is abundant on prostate cancer cells, so a PET scan using a radioactive chemical that attaches to PSMA shows where prostate cancer is, but this test has drawbacks: it is not widely available, it is expensive, and it exposes patients to radiation. This evidence concerns the gene FOLH1 and Familial prostate cancer.